Viewing nowDapagliflozin Propanediol Monohydrate 10 mg Tablet
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Kims Pharmaceutical Co., Ltd.

MFDS item code 202202246 · Approved 2022.05.26 · Insurance code 059600700
Improvement of blood glucose control in type 2 diabetes mellitus; prevention of complications of chronic heart failure and chronic kidney disease
This medication is used in conjunction with dietary and exercise therapy to help control blood sugar levels in patients with type 2 diabetes. It is also helpful in reducing the risk of death and hospitalization due to cardiovascular disease in patients with chronic heart failure. In patients with chronic kidney disease, it plays a role in reducing the risk of worsening kidney function and complications related to cardiovascular disease. This medication is often used effectively in combination with other treatments. Therefore, it is used for the treatment of type 2 diabetes, chronic heart failure, and chronic kidney disease.
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other blood glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no prior history of antidiabetic drug treatment who are receiving this medicine in combination with metformin, the recommended initial dose is 5mg once daily or 10mg once daily. Chronic heart failure and chronic kidney disease The recommended dose of this medicine is 10 mg once daily. Special populations Renal impairment - eGFR < 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - eGFR < 25 mL/min/1.73m2: Initiation of this medicine is not recommended in patients with chronic heart failure and chronic kidney disease. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be administered orally once daily at any time of day, with or without food. Tablets should be swallowed whole.
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.
This medication should not be administered to specific patients. For example, patients with allergies to any ingredients or excipients of this medication, patients with type 1 diabetes, diabetic ketoacidosis, lactose intolerance, and those undergoing dialysis should not take this medication. Use this medication with caution in patients with decreased fluid volume or poor kidney function. Since this medication can lower blood pressure or affect kidney function, the condition should be closely monitored before and after administration. While taking this medication, side effects such as genital infections, urinary tract infections, hypoglycemia, decreased fluid volume, and diabetic ketoacidosis may occur, and symptoms should be discussed with a healthcare professional immediately upon onset. Particularly, elderly patients or those with reduced kidney function are at higher risk of side effects and should be monitored more closely. Pregnant or breastfeeding women are advised not to use this medication, and usage should be discontinued upon confirmation of pregnancy. When used with insulin or sulfonylureas, the risk of hypoglycemia may increase, necessitating dosage adjustments of these medications. There are no specific antidotes for overdose, and treatment should be based on symptoms. It is unclear whether dialysis can remove this medication. This medication does not significantly affect driving or operation of machinery, but caution should be taken due to the risk of hypoglycemia. Finally, safety and efficacy have not been established in children, and the medication should be kept out of reach of children.
Vulvovaginal candidiasis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, decreased fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, lumbar pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar itching, genital itching, elevated hematocrit, decreased renal clearance of creatinine in early treatment, dyslipidemia, increased serum creatinine in early treatment, elevated blood urea, weight loss, acute pyelonephritis, chest pain, rash, angioedema, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina pectoris, myocardial infarction, biliary stones, cholangitis, alcoholic liver cirrhosis, depression, suicide attempts, gastric adenocarcinoma, anaphylactic reaction, paresthesia, cerebral infarction, nerve compression, urosepsis, acute kidney injury, renal dysfunction, chest pain, edema, fever, foreign body sensation, facial edema, facial pain, warmth, flu-like symptoms, breast mass, erectile dysfunction, benign prostatic hyperplasia, breast pain, genital rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, vulvar discomfort, menstrual irregularities, hair loss, dermatitis, dry skin, allergic dermatitis, contact dermatitis, diabetic foot ulcer, hyperhidrosis eczema, nummular eczema, eczema, hyperkeratosis, nail pigmentation, skin lesions, urticaria, cold sweats, fibromyalgia, limb discomfort, muscle cramps, musculoskeletal discomfort, osteoporosis, muscular weakness, contusions, road traffic accidents, drug overdose, ankle fractures, hand fractures, pelvic fractures, meniscus injuries, thoracic vertebra fractures, tibia fractures, dental trauma, dry eye syndrome, ocular pain, retinal disorders, vision impairment, blepharitis, cataracts, conjunctival edema, allergic conjunctivitis, conjunctivitis, diplopia, eyelid swelling, keratitis, ocular hypertension, visual impairment, vitreal floaters, oropharyngeal pain, allergic rhinitis, asthma, voice disorders, epistaxis, sleep apnea syndrome, wheezing, arteriosclerosis, flushing, peripheral coldness, varicose veins, vascular headache, orthostatic hypotension, atrial fibrillation, diastolic dysfunction, palpitations, anxiety disorders, auditory hallucinations, sleep disorders, insomnia, fatty liver, gallbladder polyps, dizziness, tinnitus, nocturia, anal genital warts, adenoma, neuroma, pituitary neoplasm of unspecified type, male hypogonadism, thyroid cysts, thyroid nodules, food allergies, erythrocytosis, dyspepsia, nausea, diarrhea, vomiting, urinary retention, increased alanine aminotransferase, increased aspartate aminotransferase, decreased appetite, lethargy, headaches, nasopharyngitis, upper respiratory infections, hunger, vaginal discharge, itching, arthralgia, musculoskeletal pain, limb pain, myalgia, osteoarthritis, ligament sprains, diabetic retinopathy, cough, dyspnea
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture, preferably at room temperature between 1 and 30 degrees Celsius. Storing it this way will safely maintain the effectiveness of the medication.
Yellow, biconvex diamond-shaped film-coated tablet
PTP - 28 tablets/box [(28 tablets (7 tablets/PTP x 4))], bottle - 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Kims Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Sung IS Co., Ltd.
Dapagliflozin Propanediol Hydrate
Prescription medication
Optus Pharmaceutical Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Aprogen Biologics Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.